The global Protein Design and Engineering market size was accounted at USD 4.50 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030. The Protein engineering and designing techniques are used to identify specific amino acid sequence changes and alter this sequence for desired functional properties. Mainly computational simulation methods and experimental/molecular methods are utilized for protein engineering.
Major factors such as increasing government initiatives & funding for the development of protein designing systems, fast advancements in technologies are primarily driving the market growth. High prevalence of protein-deficient diseases, and the surging demand for protein engineering tools by biopharmaceutical companies is also expected to support the market growth. The increasing collaborations between companies operating in this market to develop new testing technologies and accelerate the resource-intensive process of protein engineering are enhancing the growth opportunities of the protein design and engineering market. For instance, in January 2021, Zymvol Biomodeling (Spain) collaborated with Aminoverse, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry.
However, the expensive instruments and the increasing maintenance cost of the protein engineering equipment may hinder the market growth during the estimated timeframe.
The Protein design and engineering market is segmented into the protein engineering approach used, protein types, type of application, end-users, and region. The protein engineering approach used segment comprises rational designing, directed evolution, and semi-rational designing. The rational designing segment is estimated to dominate this market during the forecast period due to its rising use in antibody and enzyme designing. The market is classified into antibodies, peptides, enzymes, vaccines, and others based on the protein types. The antibodies are expected to be the fastest-growing segment of this market, owing to their increasing applications in the medical sector. The market is grouped into therapeutics and diagnostics by type of application. The market is segmented into pharma/biotech firms, CROs (contract research organizations) & research, and academic institutes by end-users. The pharma/biotech firms are projected to hold a significant market share in the coming years due to the rising demand for advanced drug and therapy treatments to cure chronic diseases. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The Asia-Pacific market is likely to witness rapid growth during the forecast period (2019-2030) due to the well-established healthcare infrastructure, growing awareness regarding protein engineering, and the rising government efforts to develop protein designing methods.
Some of the key players operating in the protein design and engineering market are ATUM (US), Creative BioMart (US), Creative Biostructure (US), Creative Enzymes (US), Absolute Antibody (UK), EUCODIS Bioscience (Austria), Fusion Antibodies (UK), Innovagen (Sweden), ZYMVOL (Spain), Averring Biotech, EnzymeWorks (China), GeNext Genomics (India), Quantumzyme (India), and others.
Global Protein Design and Engineering Market, by Protein Types, 2019-2030 (Value US$ Mn)
